Form 8-K - Current report:
SEC Accession No. 0001493152-25-009686
Filing Date
2025-03-10
Accepted
2025-03-10 16:05:26
Documents
14
Period of Report
2025-03-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55307
  Complete submission text file 0001493152-25-009686.txt   275781

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hepa-20250310.xsd EX-101.SCH 3272
3 XBRL DEFINITION FILE hepa-20250310_def.xml EX-101.DEF 29605
4 XBRL LABEL FILE hepa-20250310_lab.xml EX-101.LAB 35952
5 XBRL PRESENTATION FILE hepa-20250310_pre.xml EX-101.PRE 26662
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4936
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 25723664
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)